Luke Evnin

TriTACs, a Novel Class of T-Cell–Engaging Protein Constructs Designed for the Treatment of Solid Tumors

Richard J. Austin, Bryan D. Lemon, Wade H. Aaron et al. · Molecular Cancer Therapeutics · 2020 · 64 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized Controlled Trial to Evaluate an Internet‐Based Self‐Management Program in Systemic Sclerosis

Dinesh Khanna, Jennifer Serrano, Veronica J. Berrocal et al. · Arthritis Care & Research · 2018 · 49 citations · Full text

Nursing, Educational Technology, Chronic Illness Self-management +16

Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry

Victoria K. Shanmugam, Tracy Frech, Virginia Steen et al. · Clinical Rheumatology · 2019 · 19 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +6

Does hand involvement in systemic sclerosis limit completion of patient-reported outcome measures?

Tracy Frech, John M. VanBuren, Emily Startup et al. · Clinical Rheumatology · 2020 · 11 citations · Full text

Medicine, Neurology, Rehabilitation +7

Design of CONQUEST, a novel, randomized, placebo-controlled, Phase 2b platform clinical trial to investigate new treatments for patients with early active systemic sclerosis with interstitial lung disease

Dinesh Khanna, Luke Evnin, Shervin Assassi et al. · Journal of Scleroderma and Related Disorders · 2024 · 11 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9